NEOLEUKIN THERAPEUTICS INC (NLTX)
Institutional ownership reported to the SEC as of Q3 2023, across 17 quarters.
30
Reporting holders
$13.8M
Reported value
0.1%
Held as options
-5
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2023 | 30 | $13.8M | 3,485,929 | 30 | 0 | 0 | 0.1% |
| Q2 2023 | 35 | $13.6M | 16,346,778 | 6 | 2 | 8 | 0.1% |
| Q1 2023 | 32 | $9.3M | 13,319,053 | 4 | 5 | 10 | 0.1% |
| Q4 2022 | 35 | $7.0M | 13,776,534 | 7 | 4 | 11 | 0.0% |
| Q3 2022 | 48 | $12.0M | 18,719,093 | 4 | 6 | 19 | 0.0% |
| Q2 2022 | 56 | $21.6M | 20,818,744 | 10 | 15 | 19 | 0.7% |
| Q1 2022 | 78 | $46.9M | 24,577,513 | 13 | 24 | 26 | 1.2% |
| Q4 2021 | 77 | $121.0M | 24,682,847 | 15 | 23 | 24 | 1.7% |
| Q3 2021 | 83 | $187.4M | 25,853,719 | 8 | 24 | 26 | 0.2% |
| Q2 2021 | 84 | $251.4M | 26,950,230 | 9 | 26 | 22 | 1.1% |
| Q1 2021 | 81 | $345.6M | 27,774,697 | 5 | 20 | 33 | 1.1% |
| Q4 2020 | 85 | $396.3M | 27,726,118 | 20 | 29 | 20 | 1.4% |
| Q3 2020 | 81 | $331.1M | 27,548,554 | 20 | 33 | 13 | 0.2% |
| Q2 2020 | 76 | $418.2M | 25,135,480 | 26 | 27 | 12 | 0.2% |
| Q1 2020 | 62 | $259.7M | 22,749,606 | 18 | 17 | 13 | 0.4% |
| Q4 2019 | 58 | $246.0M | 19,855,162 | 27 | 9 | 13 | 0.6% |
| Q3 2019 | 36 | $53.7M | 18,839,836 | 36 | 0 | 0 | 0.0% |